Skip to content
2000
Volume 25, Issue 27
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Background

MMP1 (matrix metallopeptidase 1) plays a significant role in the degradation of collagen fibres within the extracellular matrix, and has been linked to a multitude of biological processes, including rheumatoid arthritis, osteoarthritis, periodontal disease, and tumor invasion.

Objective

In order to discover inhibitors of MMP1 that originate from the phytochemicals of the dandelion (.-Mazz.).

Methods

The herbal constituents of the dandelion were retrieved from the HERB database. A multifaceted approach including molecular docking, MMP1 enzyme assays, and molecular dynamics simulations was used to identify potential MMP1 inhibitors among the chemical compounds present in the dandelion.

Results

A total of 61 chemical constituents of the dandelion were collated from the HERB database. A potential MMP1 inhibitor was identified through a combination of molecular docking and an MMP1 enzyme bioactivity assay. Cichoric acid demonstrated pronounced inhibitory activity against MMP1, with an IC value of 7.81 ± 2.60 μM. Molecular dynamics simulations and binding free energy calculations indicated that the nonpolar interaction energies of LEU181, ARG214, VAL215, HIS218, GLU219, HIS228, PRO238, and SER239 played a primary role in the binding of cichoric acid to MMP1.

Conclusion

The integration of molecular modeling and bioactivity testing proved an effective method for the rapid discovery of targeted small molecule inhibitors. Cichoric acid demonstrated potent MMP1 inhibitory activity and thus represented a promising candidate for further development.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266387669250509094221
2025-05-12
2026-02-26

  • From This Site

    /content/journals/ctmc/10.2174/0115680266387669250509094221
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BianY. XiangZ. WangY. RenQ. ChenG. XiangB. WangJ. ZhangC. PeiS. GuoS. XiaoL. Immunomodulatory roles of metalloproteinases in rheumatoid arthritis.Front. Pharmacol.202314128545510.3389/fphar.2023.1285455 38035026
     [Google Scholar]
  2. ChangM. Matrix metalloproteinase profiling and their roles in disease.RSC Advances20231396304631610.1039/D2RA07005G 36825288
     [Google Scholar]
  3. KumarG.B. NairB.G. PerryJ.J.P. MartinD.B.C. Recent insights into natural product inhibitors of matrix metalloproteinases.MedChemComm201910122024203710.1039/C9MD00165D 32904148
     [Google Scholar]
  4. Cabral-PachecoG.A. Garza-VelozI. Castruita-De la RosaC. Ramirez-AcuñaJ.M. Perez-RomeroB.A. Guerrero-RodriguezJ.F. Martinez-AvilaN. Martinez-FierroM.L. The roles of matrix metalloproteinases and their inhibitors in human diseases.Int. J. Mol. Sci.20202124973910.3390/ijms21249739 33419373
     [Google Scholar]
  5. PulikŁ. ŁęgoszP. MotylG. Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: A state of the art review.Reumatologia202361319120110.5114/reum/168503 37522140
     [Google Scholar]
  6. LiW. SajiS. SatoF. NodaM. ToiM. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.Int. J. Biol. Markers201328211713010.1016/j.bbamcr.2017.04.011 23787494
     [Google Scholar]
  7. RaduA.F. BungauS.G. Management of rheumatoid arthritis: An overview.Cells20211011285710.3390/cells10112857 34831081
     [Google Scholar]
  8. AliverniniS. FiresteinG.S. McInnesI.B. The pathogenesis of rheumatoid arthritis.Immunity202255122255227010.1016/j.immuni.2022.11.009 36516818
     [Google Scholar]
  9. DingQ. HuW. WangR. YangQ. ZhuM. LiM. CaiJ. RoseP. MaoJ. ZhuY.Z. Signaling pathways in rheumatoid arthritis: Implications for targeted therapy.Signal Transduct. Target. Ther.2023816810.1038/s41392‑023‑01331‑9 36797236
     [Google Scholar]
  10. FraenkelL. BathonJ.M. EnglandB.R. St ClairE.W. ArayssiT. CarandangK. DeaneK.D. GenoveseM. HustonK.K. KerrG. KremerJ. NakamuraM.C. RussellL.A. SinghJ.A. SmithB.J. SparksJ.A. VenkatachalamS. WeinblattM.E. Al-GibbawiM. BakerJ.F. BarbourK.E. BartonJ.L. CappelliL. ChamseddineF. GeorgeM. JohnsonS.R. KahaleL. KaramB.S. KhamisA.M. Navarro-MillánI. MirzaR. SchwabP. SinghN. TurgunbaevM. TurnerA.S. YaacoubS. AklE.A. 2021 American College of rheumatology guideline for the treatment of rheumatoid arthritis.Arthritis Care Res. (Hoboken)202173792493910.1002/acr.24596 34101387
     [Google Scholar]
  11. PadyukovL. Genetics of rheumatoid arthritis.Semin. Immunopathol.2022441476210.1007/s00281‑022‑00912‑0 35088123
     [Google Scholar]
  12. DaiQ. ZhouD. XuL. SongX. Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats.Drug Des. Devel. Ther.2018124095410510.2147/DDDT.S175763 30584274
     [Google Scholar]
  13. YuZ. WangY. LiY. LiaoC. DaiJ. LuoY. HuY. TaoS. TangJ. ChenG. WuP. Effect of Moxibustion on the serum levels of MMP‐1, MMP‐3, and VEGF in patients with rheumatoid arthritis.Evid. Based Complement. Alternat. Med.202020201715060510.1155/2020/7150605 33014110
     [Google Scholar]
  14. CaiM. NiW.J. HanL. ChenW.D. PengD.Y. Research progress of therapeutic enzymes and their derivatives: Based on herbal medicinal products in rheumatoid arthritis.Front. Pharmacol.20211262634210.3389/fphar.2021.626342 33796022
     [Google Scholar]
  15. LeiZ. JianM. LiX. WeiJ. MengX. WangZ. Biosensors and bioassays for determination of matrix metalloproteinases: State of the art and recent advances.J. Mater. Chem. B Mater. Biol. Med.20208163261329110.1039/C9TB02189B 31750853
     [Google Scholar]
  16. Ben MridR. BouchmaaN. AinaniH. El FatimyR. MalkaG. MaziniL. Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis.Biomed. Pharmacother.202215111312610.1016/j.biopha.2022.113126 35643074
     [Google Scholar]
  17. LiR.L. DuanH.X. LiangQ. HuangY.L. WangL.Y. ZhangQ. WuC.J. LiuS.Q. PengW. Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis.Front. Immunol.202213104681010.3389/fimmu.2022.1046810 36439173
     [Google Scholar]
  18. PujimulyaniD. SuryaniC.L. SetyowatiA. HandayaniR.A.S. ArumwardanaS. WidowatiW. MarufA. Cosmeceutical potentials of Curcuma mangga Val. extract in human BJ fibroblasts against MMP1, MMP3, and MMP13.Heliyon202069e0492110.1016/j.heliyon.2020.e04921 32995615
     [Google Scholar]
  19. LeeM.S. OhY.J. KimJ.W. HanK.M. KimD.S. ParkJ.W. KimH.M. KimD.W. KimY.S. Antioxidant, Whitening, Antiwrinkle, and Anti-Inflammatory Effect of Ajuga spectabilis Nakai Extract.Plants20221217910.3389/fimmu.2022.1046810 36616208
     [Google Scholar]
  20. SuzukiT. OhishiT. TanabeH. MiyoshiN. NakamuraY. Anti-inflammatory effects of dietary polyphenols through inhibitory activity against metalloproteinases.Molecules20232814542610.3390/molecules28145426 37513300
     [Google Scholar]
  21. NohE.M. KimJ.S. HurH. ParkB.H. SongE.K. HanM.K. KwonK.B. YooW.H. ShimI.K. LeeS.J. YounH.J. LeeY.R. Cordycepin inhibits IL-1 -induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts.Rheumatology (Oxford)2008481454810.1093/rheumatology/ken417 19056796
     [Google Scholar]
  22. BruceC. ThomasP.S. The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity.Toxicol. Appl. Pharmacol.2005205212613210.1093/rheumatology/ken417 15893540
     [Google Scholar]
  23. StewardW.P. ThomasA.L. Marimastat: The clinical development of a matrix metalloproteinase inhibitor.Expert Opin. Investig. Drugs200091229132922 11093361
     [Google Scholar]
  24. YurtalZ. OzkanH. KutluT. DeveciM. UrfaliB. UrfaliS. The matrix metalloproteinase Ýnhibitor batimastat reduces epidural fibrosis after laminectomy in rats.Turk Neurosurg.202333116217010.5137/1019‑5149.JTN.41841‑22.2 36482856
     [Google Scholar]
  25. KumarA. BhatnagarS. KumarA. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.Am. J. Pathol.2010177124826010.2353/ajpath.2010.091176 20472898
     [Google Scholar]
  26. Di SebastianoP. di MolaF.F. ArteseL. RossiC. MascettaG. PernthalerH. InnocentiP. Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.Digestion200163423423910.1159/000051895 11435723
     [Google Scholar]
  27. YangJ-S. LinC-W. SuS-C. YangS-F. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.Expert Opin. Drug Metab. Toxicol.201612219120010.1517/17425255.2016.113182026852787
     [Google Scholar]
  28. PurcellW.T. RudekM.A. HidalgoM. Development of matrix metalloproteinase inhibitors in cancer therapy.Hematol. Oncol. Clin. North Am.20021651189122710.1016/s0889‑8588(02)00044‑8 12512389
     [Google Scholar]
  29. FerranteK. WinogradB. CanettaR. Promising new developments in cancer chemotherapy.Cancer Chemother. Pharmacol.1999437S61S68(Suppl.)10.1007/s00280005110010357561
     [Google Scholar]
  30. ShiY. MaX. FangG. TianX. GeC. Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: Recent progress and current challenges.NanoImpact20212110029310.1016/j.impact.2021.100293 35559782
     [Google Scholar]
  31. WinerA. AdamsS. MignattiP. Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future successes.Mol. Cancer Ther.20181761147115510.1158/1535‑7163.MCT‑17‑0646 29735645
     [Google Scholar]
  32. Raeeszadeh-SarmazdehM. DoL. HritzB. Metalloproteinases and their inhibitors: Potential for the development of new therapeutics.Cells202095131310.3390/cells9051313 32466129
     [Google Scholar]
  33. JillianM. JillianM. Cathcart. CaoJ. MMP Inhibitors:Past, present and future.Front. Biosci.201520711641178
     [Google Scholar]
  34. VandenbrouckeR.E. LibertC. Is there new hope for therapeutic matrix metalloproteinase inhibition?Nat. Rev. Drug Discov.2014131290492710.1038/nrd4390 25376097
     [Google Scholar]
  35. MillerM.C. ManningH.B. JainA. TroebergL. DudhiaJ. EssexD. SandisonA. SeikiM. NanchahalJ. NagaseH. ItohY. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.Arthritis Rheum.200960368669710.1002/art.24331 19248098
     [Google Scholar]
  36. AgereS.A. AkhtarN. WatsonJ.M. AhmedS. RANTES/CCL5 induces collagen degradation by activating MMP-1 and MMP-13 expression in human rheumatoid arthritis synovial fibroblasts.Front. Immunol.20178134110.1002/cmdc.200900309 29093715
     [Google Scholar]
  37. HaoL. WanY. XiaoJ. TangQ. DengH. ChenL. A study of Sirt1 regulation and the effect of resveratrol on synoviocyte invasion and associated joint destruction in rheumatoid arthritis.Mol. Med. Rep.20171645099510610.3892/mmr.2017.7299 28849139
     [Google Scholar]
  38. WuJ. SunJ. LiuM. ZhangX. KongL. MaL. JiangS. LiuX. MaW. Botany, traditional use, phytochemistry, pharmacology and quality control of Taraxaci herba: Comprehensive review.Pharmaceuticals20241791113 39338278
     [Google Scholar]
  39. LiuF.J. YangJ. ChenX.Y. YuT. NiH. FengL. LiP. LiH.J. Chemometrics integrated with in silico pharmacology to reveal antioxidative and anti-inflammatory markers of dandelion for its quality control.Chin. Med.202217112510.1186/s13020‑022‑00679‑4 36333721
     [Google Scholar]
  40. FanM. ZhangX. SongH. ZhangY. Dandelion (Taraxacum Genus): A review of chemical constituents and pharmacological effects.Molecules20232813502210.1002/cmdc.200900309 37446683
     [Google Scholar]
  41. WangR. LiW. FangC. ZhengX. LiuC. HuangQ. Extraction and identification of new flavonoid compounds in dandelion Taraxacum mongolicum Hand.-Mazz. with evaluation of antioxidant activities.Sci. Rep.2023131216610.3390/molecules28135022 36750602
     [Google Scholar]
  42. ZouH. BenT. WuP. WaterhouseG.I.N. ChenY. Effective anti-inflammatory phenolic compounds from dandelion: identification and mechanistic insights using UHPLC-ESI-MS/MS, fluorescence quenching and anisotropy, molecular docking and dynamics simulation.Food Sci. Hum. Wellness20231262184219410.1016/j.fshw.2023.03.031
     [Google Scholar]
  43. YanQ. XingQ. LiuZ. ZouY. LiuX. XiaH. The phytochemical and pharmacological profile of dandelion.Biomed. Pharmacother.2024179117334 39180794
     [Google Scholar]
  44. FatimaT. BashirO. NaseerB. HussainS.Z. Dandelion: Phytochemistry and clinical potential.J. Med. Plants Stud20186198202
     [Google Scholar]
  45. Kania-DobrowolskaM. BaraniakJ. Dandelion (Taraxacum officinale L.) as a source of biologically active compounds supporting the therapy of co-existing diseases in metabolic syndrome.Foods20221118285810.3390/foods11182858 36140985
     [Google Scholar]
  46. XieJ. HuangY. WangQ. Research progress of anti-tumor active ingredients in Dandelion.J. Oncol. Research202022243010.30564/jor.v2i2.2472
     [Google Scholar]
  47. MajewskiM. LisB. JuśkiewiczJ. OgnikK. Borkowska-SztachańskaM. JedrejekD. StochmalA. OlasB. Phenolic fractions from dandelion leaves and petals as modulators of the antioxidant status and lipid profile in an in vivo study.Antioxidants20209213110.3390/antiox9020131 32028583
     [Google Scholar]
  48. FangS. DongL. LiuL. GuoJ. ZhaoL. ZhangJ. BuD. LiuX. HuoP. CaoW. DongQ. WuJ. ZengX. WuY. ZhaoY. HERB: A high-throughput experiment- and reference-guided database of traditional Chinese medicine.Nucleic Acids Res.202149D1D1197D120610.1093/nar/gkaa1063 33264402
     [Google Scholar]
  49. WuJ. ZhouW. WangJ. RuLi. GuoZ. HuangC. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines.J. Cheminform20146131610.1186/1758‑2946‑6‑13
     [Google Scholar]
  50. HuangL. XieD. YuY. LiuH. ShiY. ShiT. WenC. TCMID 2.0: A comprehensive resource for TCM.Nucleic Acids Res.201846D1D1117D112010.1093/nar/gkx1028 29106634
     [Google Scholar]
  51. WuY. ZhangF. YangK. FangS. BuD. LiH. SunL. HuH. GaoK. WangW. ZhouX. ZhaoY. ChenJ. SymMap: An integrative database of traditional Chinese medicine enhanced by symptom mapping.Nucleic Acids Res.201947D1D1110D1117 30380087
     [Google Scholar]
  52. JiZ.L. ZhouH. WangJ.F. HanL.Y. ZhengC.J. ChenY.Z. Traditional Chinese medicine information database.J. Ethnopharmacol.2006103350110.1016/j.jep.2005.11.003 16376038
     [Google Scholar]
  53. LigPrep, version 23.New York, NYSchrödinger, LLC2017
     [Google Scholar]
  54. Schrodinger ¨ Release 2017-3: LigPrep.New York, NYS., LLC2020
     [Google Scholar]
  55. KaminskiG.A. FriesnerR.A. Tirado-RivesJ. JorgensenW.L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides.J. Phys. Chem. B2001105286474648710.1021/jp003919d
     [Google Scholar]
  56. Epik, version 20.New York, NYSchrödinger, LLC2017
     [Google Scholar]
  57. SpurlinoJ.C. SmallwoodA.M. CarltonD.D. BanksT.M. VavraK.J. JohnsonJ.S. CookE.R. FalvoJ. WahlR.C. PulvinoT.A. WendoloskiJ.J. SmithD.L. 1.56 Å structure of mature truncated human fibroblast collagenase.Proteins19941929810910.1002/prot.340190203 8090713
     [Google Scholar]
  58. FriesnerR.A. BanksJ.L. MurphyR.B. HalgrenT.A. KlicicJ.J. MainzD.T. RepaskyM.P. KnollE.H. ShelleyM. PerryJ.K. ShawD.E. FrancisP. ShenkinP.S. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.J. Med. Chem.20044771739174910.1021/jm0306430 15027865
     [Google Scholar]
  59. KatoN. KobayashiT. HondaH. Screening of stress enhancer based on analysis of gene expression profiles: Enhancement of hyperthermia‐induced tumor necrosis by an MMP‐3 inhibitor.Cancer Sci.200394764464910.1111/j.1349‑7006.2003.tb01497.x 12841876
     [Google Scholar]
  60. LimH. KimH.P. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids.Planta Med.2007731212671274 17886198
     [Google Scholar]
  61. WangJ. WolfR.M. CaldwellJ.W. KollmanP.A. CaseD.A. Development and testing of a general amber force field.J. Comput. Chem.20042591157117410.1002/jcc.20035 15116359
     [Google Scholar]
  62. BaylyC.I. CieplakP. CornellW. KollmanP.A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model.J. Phys. Chem.199397401026910280
     [Google Scholar]
  63. RomeliaS.F. DavidA. WalkerR.C. An overview of the Amber biomolecular simulation package.Wiley Interdiscip Rev. Comput. Mol. Sci.20133219821010.1002/wcms.1121
     [Google Scholar]
  64. MaierJ.A. MartinezC. KasavajhalaK. WickstromL. HauserK.E. SimmerlingC. ff14SB: Improving the Accuracy of protein side chain and backbone parameters from ff99SB.J. Chem. Theory Comput.20151183696371310.1021/acs.jctc.5b0025 26574453
     [Google Scholar]
  65. OnufrievA.V. IzadiS. Water models for biomolecular simulations.Wiley Interdiscip. Rev. Comput. Mol. Sci.201882e1347
     [Google Scholar]
  66. PanD. HuangY. JiangD. ZhangY. WuM. HanM. JinX. Discovery of an EP300 inhibitor using structure-based virtual screening and bioactivity evaluation.Curr. Pharm. Des.2024302519851994 38835125
     [Google Scholar]
  67. MillerB.R. McGeeT.D. SwailsJ.M. HomeyerN. GohlkeH. RoitbergA.E. MMPBSA.py: An efficient program for end-state free energy calculations.J. Chem. Theory Comput.2012893314332110.1021/ct300418h 26605738
     [Google Scholar]
  68. JaliliC. TaghadosiM. PazhouhiM. BahrehmandF. MiraghaeeS. PourmandD. RashidiI. An overview of therapeutic potentials of Taraxacum officinale (dandelion): A traditionally valuable herb with a reach historical background.World Cancer Res. J.20207119
     [Google Scholar]
  69. CommissionC.P. Chinese pharmacopeia.China Chemical Industry Press2020367
     [Google Scholar]
  70. DiY. SongY. XuK. WangQ. ZhangL. LiuQ. ZhangM. LiuX. WangY. Chicoric acid alleviates colitis via targeting the gut microbiota accompanied by maintaining intestinal barrier integrity and inhibiting inflammatory responses.J. Agric. Food Chem.202472126276628810.1016/j.intimp.2022.109129 38485738
     [Google Scholar]
  71. QuY. ShenY. TengL. HuangY. YangY. JianX. FanS. WuP. FuQ. Chicoric acid attenuates tumor necrosis factor-α-induced inflammation and apoptosis via the Nrf2/HO-1, PI3K/AKT and NF-κB signaling pathways in C28/I2 cells and ameliorates the progression of osteoarthritis in a rat model.Int. Immunopharmacol.2022111109129 35961266
     [Google Scholar]
  72. LiuQ. FangJ. ChenP. DieY. WangJ. LiuZ. LiuX. Chicoric acid improves neuron survival against inflammation by promoting mitochondrial function and energy metabolism.Food Funct.20191096157616910.1039/C9FO01417A 31501849
     [Google Scholar]
  73. Abd El-TwabS.M. HusseinO.E. HozayenW.G. Bin-JumahM. MahmoudA.M. Chicoric acid prevents methotrexate-induced kidney injury by suppressing NF-κB/NLRP3 inflammasome activation and up-regulating Nrf2/ARE/HO-1 signaling.Inflamm. Res.201968651152310.1007/s00011‑019‑01241‑z 31037316
     [Google Scholar]
  74. TsaiK.L. KaoC.L. HungC.H. ChengY.H. LinH.C. ChuP.M. Chicoric acid is a potent anti-atherosclerotic ingredient by anti-oxidant action and anti-inflammation capacity.Oncotarget2017818296002961210.18632/oncotarget.16768 28410194
     [Google Scholar]
  75. LeeN.Y. ChungK.S. JinJ.S. BangK.S. EomY.J. HongC.H. NugrohoA. ParkH.J. AnH.J. Effect of chicoric acid on mast cell-mediated allergic inflammation in vitro and in vivo.J. Nat. Prod.201578122956296210.1021/acs.jnatprod.5b00668 26593037
     [Google Scholar]
  76. XueC. AS. WangM. WuQ. LiuJ. ZhangL. WuY. WuH. ChaiS. Echinacea purpurea extract (cichoric acid) exerts an anti-inflammatory effect on yak PBMCs and regulates the TLR4 signalling pathway.J. Vet. Res. (Pulawy)202165110911510.2478/jvetres‑2021‑0016 33817403
     [Google Scholar]
  77. JiaL. ChenY. TianY.H. ZhangG. MAPK pathway mediates the anti-oxidative effect of chicoric acid against cerebral ischemia-reperfusion injury in vivo.Exp. Ther. Med.20181521640164629434748
     [Google Scholar]
/content/journals/ctmc/10.2174/0115680266387669250509094221
Loading
Discovery of MMP1 Inhibitors from Dandelion using Molecular Simulation and Bioactivity Test
Curr. Top. Med. Chem. 25, 3203 (2025); https://doi.org/10.2174/0115680266387669250509094221
/content/journals/ctmc/10.2174/0115680266387669250509094221
/content/journals/ctmc/10.2174/0115680266387669250509094221
Loading

Data & Media loading...

Supplements

file format download Download

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): binding free energy calculation; cichoric acid; dandelion; MMP1 inhibitor; molecular dynamics simulation; structure-based virtual screening

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test